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In mammals, the extended amygdala is a neural hub for social and emotional information 
processing. In the rat, the extended amygdala receives inhibitory GABAergic projections from 
the nucleus incertus (NI) in the pontine tegmentum. NI neurons produce the neuropeptide 
relaxin-3, which acts via the Gi/o-protein-coupled receptor, RXFP3. A putative role for RXFP3 
signalling in regulating social interaction was investigated by assessing the effect of 
intracerebroventricular infusion of the RXFP3 agonist, RXFP3-A2, on performance in the 3-
chamber social interaction paradigm. Central RXFP3-A2, but not vehicle, infusion, disrupted 
the capacity to discriminate between a familiar and novel conspecific subject, but did not alter 
differentiation between a conspecific and an inanimate object. Subsequent studies revealed that 
agonist-infused rats displayed increased pERK-immunoreactivity in specific amygdaloid nuclei 
at 20 min post-infusion, with levels similar to control again after 90 min. In parallel, we used 
immunoblotting to profile ERK phosphorylation dynamics in whole amygdala after RXFP3-
A2 treatment; and multiplex histochemical labelling techniques to reveal that after RXFP3-A2 
infusion and social interaction, pERK-immunopositive neurons in amygdala expressed 
vesicular GABA-transporter mRNA and displayed differential profiles of RXFP3 and oxytocin 
receptor mRNA. Overall, these findings demonstrate that central relaxin-3/RXFP3 signalling 
can modulate social recognition in rats via effects within the amygdala and likely interactions 









The capacity to identify and recall familiar conspecifics is crucial for appropriate social 
interaction and its absence is associated with impaired social abilities ranging from borderline 
personality disorder (Servan et al. 2017) to schizophrenia (Davis et al. 2014; Green et al. 2015) 
and autism spectrum disorders (Happé and Conway 2016). Social identification of conspecifics 
is intimately related to social recognition memory (SRM), a key process underlying long-term, 
socially-related behaviours, including pair bonding, aggression and mating (Dantzer et al. 1987; 
Gheusi et al. 1994; Williams et al. 2006; Maski et al. 2015). The amygdala is responsible for 
recognition of emotional facial expressions in humans (Baxter and Murray 2002; Seymour and 
Dolan 2008; Vuilleumier and Sander 2008; Gupta et al. 2011; Benarroch 2015; Bonnet et al. 
2015) and social relationship pair-bonding in humans and rodents (Gobrogge et al. 2009; 
Hurlemann et al. 2010). 
In rodents, conspecifics are recognized by olfactory information entering the amygdala 
from the main and accessory olfactory bulbs (Scalia and Winans 1975; Ferguson et al. 2001; 
Pro-Sistiaga et al. 2007; Trainor et al. 2010). Within the amygdala, the medial (MeA) nuclei 
and the bed nucleus of the stria terminalis (ST)1, process social cues (Alheid et al. 1998; Rasia-
Filho et al. 2000; Alheid 2006; Pereira et al. 2013; Fox et al. 2015) and, in turn, send projections 
to the hypothalamus (Hatalski et al. 1998; Smith and Vale 2006; Veenema 2008) and 
hippocampus (Hitti and Siegelbaum 2014; Okuyama et al. 2016). Ascending monoaminergic 
projections from neurons located in the brainstem also modulate aspects of social behaviour 
(Korzan et al. 2001; Arakawa 2017). 
In a similar fashion, neurons in the nucleus incertus (NI), located in the pontine tegmentum, 
innervate the amygdala and other regions involved in social behaviour (Olucha-Bordonau et al. 
2003; Ryan et al. 2011; Santos et al. 2016). The NI is characterized by GABA neurons that co-
express relaxin-3 (RLN3), a member of the insulin/relaxin superfamily (Bathgate et al. 2002; 
Burazin et al. 2002; Ma et al. 2007, 2017). The impact of the NI GABA/RLN3 system on 
amygdala and extended amygdala-related behaviours has been described in various paradigms, 
including fear acquisition (Lee et al. 2014), extinction (Pereira et al. 2013), anxiety (Ryan et al. 
2013a), feeding (Lenglos et al. 2014), and alcohol-seeking (Ryan et al. 2013b). 
RLN3 is the cognate ligand of relaxin-family peptide receptor 3 (RXFP3), which is a Gi/o-
protein-coupled receptor (Bathgate et al. 2002; Liu et al. 2003). Recent studies indicate that 
RXFP3 activation predominantly produces hyperpolarization of RXFP3 mRNA-positive 
neurons in rat brain slices, including magnocellular and parvocellular oxytocin neurons 
(Blasiak et al. 2013; Kania et al. 2017), consistent with inhibition of adenylate cyclase and 
reduced cellular cAMP levels associated with Gi/o-coupled receptor activation in cell-based 
systems (Liu et al. 2003; Halls et al. 2007). RXFP3 activation rapidly activates cellular 
externally-regulated kinases (ERKs) in vitro (Van der Westhuizen et al. 2007, 2010; Kocan et 
al. 2014); and in vivo, intracerebroventricular (icv) RXFP3 agonist injection produced increased 
levels of phosphorylated ERK (pERK) in rat medial septal cholinergic neurons (Albert-Gascó 
et al. 2017). However, this specific effect is thought to be indirect, as septal and diagonal band 
cholinergic neurons have been confirmed to be RXFP3 mRNA-negative (Albert-Gascó et al. 
2018). Nonetheless, altered pERK levels in the amygdala have been associated with social 
interaction behaviour (Richter et al. 2005; Peng et al. 2010; Giese and Mizuno 2013) and 
changes in pERK levels have been used to assess brain activity changes underlying behavioural 
social deficits (Faridar et al. 2014). 
                                                
1 The bed nucleus of the stria terminalis is abbreviated as BNST, BST or ST. However, when describing 
subdivisions of the area, the abbreviations become long and less useful. Thus, in the 7th Edition of The Rat Brain 
in Stereotaxic Coordinates, the whole bed nucleus of the stria terminalis was abbreviated as ST (Olucha-Bordonau 
et al. 2014; Paxinos and Watson 2014). 
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We hypothesized that RXFP3 activation could modulate social recognition and/or recall of 
SRM. Thus, we examined the effects of icv infusion of the selective RXFP3 agonist, RXFP3-
A2 (Shabanpoor et al. 2012; Zhang et al. 2015), on social discrimination performance in the 3-
chamber paradigm; and levels of pERK in the extended amygdala. Subsequently, we studied 
the relationship between behavioural responses and the occurrence of pERK immunoreactivity 
in RXFP3 mRNA-expressing neurons. In addition, we investigated the anatomical association 
of RLN3-positive nerve fibres with activated neurons in the amygdala, reflected by neuronal 
pERK immunostaining. Finally, we assessed the neurochemical phenotype of RXFP3 mRNA-
positive neurons in the extended amygdala by assessing the relative co-expression of Rxfp3 
mRNA with vesicular GABA-transporter (SlC32a1) and oxytocin receptor (Oxtr) mRNA. 
Overall, our findings suggest a role for RLN3/RXFP3 signalling in modulating social memory, 
which might occur via rapid alterations in ERK and related signalling in GABAergic and Oxtr-
positive neurons within specific regions of the extended amygdala. 
 
MATERIALS AND METHODS 
 
Animals and surgical procedures 
The Ethics Committee of the University Jaume I approved all procedures 
(#2015/VSC/PEA/00091). Male, Wistar rats (300-380g) were maintained on a 12-12 h light-
dark cycle with lights on at 0700 h GMT and behavioural procedures were conducted between 
10.00 and 12.00 h GMT. 
For surgical procedures, rats were anesthetised with ketamine (Imalgene 25 mg/kg i.p., 
Merial-Laboratories-SA, Barcelona, Spain) and xylazine (10 mg/kg, i.p., X1251 Sigma-
Aldrich, St Louis, MO, USA), and then a cannula was implanted at stereotaxic coordinates AP 
0.48 mm, ML 0.1 mm, DV -4 mm from bregma (Paxinos and Watson 2014) and secured with 
a screw attached to the skull. 
 
Experimental groups 
In this study, six experimental treatment groups were used. Apart from those in the naïve group, 
all rats had a cannula implanted targeting the right lateral cerebral ventricle.  
Agonist-infused and vehicle groups used for immunoblotting studies, which did not 
undergo behavioural testing, were killed 20 and 90 min after peptide or vehicle infusions. 
Alternatively, infusions of agonist and vehicle rat groups which did undergo a 3-chamber social 
interaction behavioural test, were made either 20 minutes prior the Sociability test, agonist 
infused animals were named RXFP3-A2-Soc (A2-Soc), or 20 minutes prior to the Preference 
test, agonist infused animals were named RXFP3-A2-Pref (A2-Pref) (Fig. 1a). 
 
On all cases, infusions were done one week after surgery, when the vehicle experimental group 
received 1 µl of artificial cerebrospinal fluid (aCSF) and agonist experimental groups received 
1 µl of 5 µg/µl of RXFP3-A2 [R3A(11–24, C15àA)B] specific RXFP3 agonist solution 
(Shabanpoor et al. 2012). Infusions were done at a rate of 0.5 µl/min over 2 minutes using a 
Harvard syringe injector (Harvard PHD2000 syringe pump; Harvard Apparatus, Holliston, MA, 
USA). After infusions, the injector needle was left in place for 5 minutes to avoid reflux of 
agonist or vehicle.  
 
RXFP3-A2 agonist was kindly supplied by A/Prof M Akhter Hossain (The Florey Institute of 




Three-chamber social interaction and memory test 
All rats were handled daily during the week after surgery. On the day of the behavioural test, 
rats were habituated to the behavioural room for 30 min before the vehicle or peptide infusions 
20 min prior to each trial. The behavioural test was conducted in a three-chamber apparatus. 
Each chamber measured 22 × 39 × 40 cm. On the first trial, following a 5 min habituation, each 
rat was allowed to explore either a conspecific or an inanimate object for 10 min (‘Sociability 
Test’). After a 1 h inter-trial period, in the ‘Preference Test’ each test rat was allowed to explore 
a familiar conspecific (from the sociability test) or a novel one for 10 min. The chamber in 
which the novel (stranger) rat or object were placed were balanced every two cases (agonist 
infused and control subject) in all experiments. In addition, the rat acting as stranger was also 
balanced every two cases. Finally, animals acting as subject on the sociability test were then 
change to the opposite position on the preference test. Behaviour was analysed using video-
tracking (Supplementary Fig. 1a, b). Rats were killed immediately after the preference test. 
Data were expressed as either a “sociability index”, which was calculated as the time spent 
sniffing the subject minus the time sniffing the object (sociability test), or the “preference 
index”, calculated as the time sniffing the novel conspecific minus the time sniffing the familiar 
conspecific (preference test) (Fig. 1a). Data were analysed by one way-ANOVA followed by 
a Bonferroni post-hoc test. First contact latencies, as a measure of social anxiety, was used for 
both for the Social interaction test and the Preference test. The contact was considered when 
rats being tested sniffed a conspecific, was expressed in seconds and compared between the 
different behavioural groups.  
 
Immunoblotting 
In western blot studies, pERK levels were assessed in the amygdaloid complex, as described 
(Albert-Gascó et al. 2017). In brief, rats were lightly anesthetized (Dolethal, 200 mg/Kg 
Vetoquinol S.A., Madrid, Spain) and then killed by decapitation. Brains were removed and 
frozen. The amygdala was dissected using 1 mm diameter disposable biopsy punches (Interna 
Miltex, Ratingen, Germany) from 20 µm brain slices cut using a cryostat at -15ºC to preserve 
protein phosphorylation. Brain tissue samples were lyzed in RIPA buffer containing protease 
and phosphatase inhibitors (Halt #78440 protease and phosphatase inhibitor, Thermo Scientific, 
Waltham, MA, USA). 
Equal amounts of total protein were loaded onto a polyacrylamide gel, resolved and 
transferred to Immobilon-P membranes (MERCK Millipore, Darmstadt Germany), followed 
by blocking with bovine serum albumin. Membranes and primary antibodies (anti-pERK 
antibody (E-4) Santa Cruz Biotechnology sc-7383, Santa Cruz, CA, USA; 1:500) and anti-ERK 
(Santa Cruz Biotechnology SC-7383; 1:1,000), were incubated overnight at 4ºC and for 1 h at 
room temperature with peroxidase-conjugated secondary antibodies (anti-rabbit and anti-
mouse, Jackson Immunoresearch, West Grove, PA, USA). Bands were developed using 
enhanced chemiluminescence (BioRad, Hercules CA, USA) and digital images were captured 
with a charge-coupled device imager (IMAGEQUANT LASc 4000, GE Healthcare Little 
Chalfont, UK). Immunoreactive bands were quantified with ImageJ blots toolkit software 
(National Institutes of Health, Baltimore, MD, USA). The intensity of the pERK bands was 
measured and normalized to the ERK band intensity, and data were expressed as the 
pERK/ERK ratio for each treatment, relative to that of the naïve rat group. Data were analyzed 
by one way-ANOVA followed by Bonferroni post-hoc test. 
 
Immunohistochemistry and immunofluorescence staining 
Immunohistochemistry and immunofluorescence analysis were performed as described 
(Albert-Gascó et al. 2017). Briefly, the RXFP3-A2 and naïve groups (n = 6-8/group) were 
euthanized with sodium pentobarbital (120 mg/kg, Eutanax, Fatro, Barcelona, Spain) and 
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transcardially with saline (0.9 % NaCl) followed by fixative (4 % paraformaldehyde in 0.1 M 
PB, pH 7.4) for 30 min (*600 mL per rat). Brains were then removed and immersed in fixative 
for 4 h at 4ºC. Subsequently, brains were cryoprotected in 30% sucrose in 0.01 M phosphate-
buffered saline p H7.4 for 3 days. 
Coronal sections (40 µm) from bregma 0.36 mm to -3.6 mm (Paxinos and Watson 2014) 
were obtained using a freezing slide microtome (Leica SM2010R, Heidelberg, Germany) and 
stored in sucrose-PBS. After incubation in blocking solution (10% NGS, in 0.1 M PBS, 0.3% 
Triton X-100, pH 7.6) sections were incubated overnight at room temperature with rabbit anti-
phospho-MAPK/ERK (#9101 Cell Signalling, Danvers, MA, USA; 1:200) and mouse anti-
RLN3 (Tanaka et al. 2005); 1:5) in blocking solution. 
For immunochemistry of pERK, after several rinses in PBS, sections were incubated for 1 
h in 1:200 biotinylated goat anti-rabbit secondary antibody (Jackson Immunoresearch, 111-
065-003), rinsed and transferred to avidin-biotin complex (Vectastain-Elite, Cat No. PK-6100; 
Vector Laboratories, Burlingame, CA, USA). Labelling was visualized with 0.025% DAB, 
0.0024% H2O2 in Tris-HCl buffer, pH 7.6. After final washes, sections were mounted, air-dried, 
dehydrated and coverslipped with DPX (Sigma-Aldrich). Quantification of pERK-positive 
neurons was conducted using ImageJ (National Institutes of Health). Data were expressed as 
the number of pERK-positive neurons/area and normalized to values observed in vehicle rats. 
Double-labeling immunofluorescence, was completed as described (Albert-Gascó et al. 
2017) Briefly, sections were incubated with primary antisera and then with goat anti-rabbit Cy3 
and goat anti-mouse Alexa Fluor 488 (Jackson Immunoresearch; #111-165-003, #115-545-
003). Following further rinsing, sections were mounted on slides and coverslipped using 
Fluoromount-G (#0100-01, Southern Biotech, Birmingham, AL, USA). 
 
Multiplex in situ hybridization 
In studies to evaluate ERK activation in RXFP3 mRNA-positive neurons, we combined 
detection of pERK immunofluorescence with in situ hybridization (ISH) detection of Rxfp3 
mRNA-positive neurons, using fluorescence ISH (RNAscope™; Advanced Cell Diagnostics 
(ACD); Newark, CA, USA). After behavioural testing, rats were transcardially perfused, as 
described (Albert-Gascó et al. 2017). After 18 h post-fixation at 4ºC, brain sections (30 µm) 
were collected using a vibratome (Leica VT 1200S, Wetzlar Germany) and transferred to a 
cryprotectant medium (30% ethylene glycol, 30% glycerol in phosphate buffer, pH 7.4) and 
stored at -20ºC. 
For the detection of Rxfp3 mRNA, probes covered ~1000 bp of the target mRNA. Sections 
were mounted onto Superfrost Plus Slides (Fisher Thermo Scientific, Hampton, NH, USA, 
Cat#12-550-15) and air dried. The next day, sections were fixed in 4% formaldehyde for 10 
min at 4ºC, and rinsed in PBS. Once dry, a hydrophobic barrier was drawn around the sections 
(ImmEdge hydrophobic PAP pen, Vector Laboratories, #310018). Sections were incubated 
with protease pretreatment-4 (ACD, Cat #322340) for 30 min at 40ºC. After a distilled water 
rinse, sections were incubated for 2 h at 40ºC with Rxfp3 mRNA probe (ACD, #316181). 
Following incubation, sections were rinsed with wash buffer (#310091) and the signal was 
amplified with ACD amplifier reagents. After several rinses in wash buffer and PBS, sections 
were incubated for immunofluorescence against pERK, with anti-phospho-MAPK/ERK (Cell 
Signaling 1:50) for 90 min at room temperature and Cy3 goat anti-rabbit IgG for 30 min. 
The neurochemical phenotype of Rxfp3 mRNA-expressing neurons was assessed using 
multiplex fluorescence ISH (RNAscope, ACD) using probes targeting Rxfp3 (#316181), Oxtr 




Confocal analysis was performed as described (Albert-Gascó et al. 2017). Briefly, 
immunofluorescence images were captured with a Leica DMi8 inverted microscope (Leica 
Microsystems) at 0.3 µm interval stacks. Immunofluorescent neurons were counted using 
ImageJ software (National Institutes of Health). Percentages of co-expression between pERK 
and Rxfp3 mRNA positive neurons in brains from the A2-pref group were compared to the 
vehicle-treatment group, using a Mann-Whitney test (n= 4). 
Similarly, ISH images were captured using an LSM 780 Zeiss Axio Imager 2 confocal 
laser-scanning microscope (Carl Zeiss AG, Jena, Germany). This system is equipped with a 
stitching stage, and Zen software (Carl Zeiss AG) was used to stitch tiled images taken with a 
20× objective or 40× objective. Quantification of co-expression (1 section per level and per rat) 
was conducted manually using Fiji (Schindelin et al. 2012), with labeling with each probe 
counted separately, relative to DAPI-stained nuclei, to avoid bias. 
 
RESULTS 
Icv RXFP3-A2 infusion impaired social recognition memory 
Previous studies have described robust effects of icv infusion of RXFP3 agonists within 20 min 
post–infusion (Ryan et al. 2013a; Albert-Gascó et al. 2017; de Ávila et al. 2018). Thus, we 
designed a schedule in which icv infusion of the agonist, RXFP3-A2 or vehicle, was 
administered 20 min prior to the social or preference tests. 
RXFP3 agonist treatment did not alter responses in the sociability test, as all groups of rats 
spent an average 78.4 ± 2.6% of the 10 minute duration of the test sniffing the conspecific rat 
and the sociability index was not significantly different across all groups (F2,23 = 0.30; p = 0.74, 
Fig. 1b; Supplementary Fig. 1c). However, RXFP3 agonist infusion before the sociability test 
(A2-Soc) or the preference test (A2-Pref) significantly altered the preference index, which was 
positive for control groups (naïve: 0.35 ± 0.06, n = 6; vehicle: 0.33 ± 0.07, n = 5), but negative 
for the A2-Pref (-0.14 ± 0.05, n = 5) and A2-Soc (-0.13 ± 0.06, n = 6) groups, (F3,21 = 19.14, p 
<0.0001; Fig. 1c); indicating that agonist-treated rats had no preference for novelty. This 
response can be interpreted as a deficit in recalling the familiar rat. Control groups spent >60% 
of the test duration exploring the novel conspecific, which is indicative of social memory of the 
familiar rat and preference to explore the novel rat. In contrast, agonist-treated rats spent a 
significantly longer time exploring the familiar rat (Supplementary Fig. 1d). Furthermore, the 
time exploring the familiar rat was not >60% of the test duration, ruling out any ‘bonding’ to 
the familiar conspecific. Lastly, RXFP3-A2-treated rats did not display increased locomotor 
activity compared to control groups (data not shown). When analysing social interaction first 
contact latencies A2-Soc groups (8.8s ± 3.6s, n=5) did not show a significative difference with 
either vehicle (10.27s ± 2.7s, n= 10) nor Naïve groups (13.84s ± 4.3s; n= 6) (F3,26 = 0,41, p = 
0,67; Fig 1d). In a similar manner, in the Preference test, A2-Soc (4.01s ± 1.1s, n =5) and A2-
Pref (4.755s ± 1.1s, n = 8) subjects did not show differential latencies with vehicle nor Naïve 
rats (3.8s ± 0.9s, n= 6) (F3,27 =0.59, p = 0.63; Fig.1e). Rats any condition did not show social 
anxiety as no significative differences were observed when comparing the different 
experimental groups first contact latencies. 
 
Icv RXFP3-A2 infusion rapidly increased ERK phosphorylation in amygdala 
Using western immunoblotting, we quantified ERK and pERK levels in amygdala tissue 
extracts from rats killed 20 and 90 min after RXFP3-A2 or aCSF infusions, and from naïve, 
untreated rats (Fig. 2). All data followed a normal distribution according to a Shapiro-Wilk 
normality test. When compared to naïve rats (1.00 ± 0.07, n = 8), rats receiving an aCSF 
infusion 20 min before perfusion did not display a significant increase in pERK levels (1.20 ± 
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0.08, n = 8). In contrast, rats that received RXFP3 agonist infusion (A2-20) displayed a 
significant increase of pERK levels (1.79 ± 0.2, n = 7) compared to naïve and aCSF-treated rats 
(F2, 22 =10.29, p = 0.0008; Fig. 2a, b). However, rats treated with the agonist 90 min prior to 
perfusion (A2-90) displayed a similar pERK/ERK ratio to naïve and aCSF-treated rats (0.9 ± 
0.02, n = 5; F2,14 = 1.00, p = 0.39; Fig. 2c, d). 
 
Icv RXFP3-A2 infusion increased pERK immunoreactivity in discrete amygdaloid nuclei 
after the three-chamber social interaction and memory test 
We assessed the effect of icv RXFP3-A2 infusion on cellular pERK levels in specific 
amygdaloid nuclei after the three-chamber social interaction test (Table 1). For analysis, the 
amygdala was considered in two parts: the rostral extension containing the bed nucleus of the 
stria terminalis (ST); and the temporal extension containing the medial amygdala (MeA) 
(Olucha-Bordonau et al. 2014). Within the MeA (Fig. 3a), significantly increased pERK (Fig. 
3b) was observed in the anterior dorsal part (MeAD) in the A2-Pref group (190 ± 28.0%, n = 
6) compared to the vehicle-treated (100 ± 15.4%, n = 6) and A2-Soc (101 ± 21.5%, n = 5) 
groups (F2,16 = 5.49, p = 0.017; Fig. 3c-e). Similarly, significantly increased pERK (Fig. 3b) 
was observed in the posterior ventral part (MePV) of the A2-Pref group (177.3 ± 18.9%, n = 
8), compared to the vehicle-treated (100 ± 19.4%, n = 6) and A2-Soc (133.4 ± 22.3%, n = 6) 
groups (F2,18 = 4.07, p =0.037; Fig. 3f-h). All other regions examined, did not exhibit significant 
differences in cellular pERK levels, across the groups (Table 1). 
In the ST (Fig. 4a), rats in the A2-Pref group displayed a significantly higher density of 
pERK-positive neurons in the ventral part (STMV) (275 ± 27.2, n = 8; Fig. 4b) compared to 
the A2-Soc (196 ± 49.0, n = 5) and vehicle (100 ± 21.9, n = 6) groups (F2,18 = 8.10, p = 0.04; 
Fig. 4c-e). The A2-Pref group also displayed a significantly increased density of pERK-positive 
neurons in the oval nucleus (STOV) (198 ± 29.0, n = 5) compared to the vehicle (100 ± 10.7, n 
= 5) and A2-Soc (118.5 ± 8.50, n = 5) groups (F2,11 = 6.10, p = 0.02; Fig. 4f-h). 
Using dual immunofluorescence detection of pERK and RLN3, we demonstrated putative 
close contacts between RLN3-immunoreactive fibres and pERK-positive neurons in the MeAD 
(Fig. 3i, i′), MePV (Fig. 3j, j′) and STMV (Fig. 4j, j′) in the A2-Pref group. (Densities of 
pERK-immunopositive neurons followed a normal distribution according to a Shapiro-Wilk 
normality test). 
 
Rxfp3 mRNA-positive neurons in amygdala display increased pERK immunoreactivity 
after three-chamber social interaction testing 
We conducted the three-chamber social interaction test in a separate cohort of rats and assessed 
neuronal co-expression of Rxfp3 mRNA and pERK immunofluorescence (Fig. 5a-b). In the 
MeA, the density of Rxfp3 mRNA- and pERK immunopositive neurons, was significantly 
higher in the A2-pref group than the vehicle group, in both the MeAD (27.5 ± 2.9% A2-pref vs 
7.25 ± 1.25% vehicle; n = 4; p < 0.05; Fig. 6a-b′′), and the MePV (34.5 ± 5.7% A2-pref vs 6.75 
± 1.8% vehicle; n = 4; p < 0.05; Fig. 6c-d′′). 
Analysis of co-expression of Rxfp3 mRNA and pERK immunolabeling in the OV detected 
a significantly higher level (Fig. 5a-b) in the A2-pref group than the vehicle group (29.5 ± 
0.96% versus 1.5 ± 1.5%; n = 4; p < 0.05; Fig. 6e-f′′). In contrast, although an increased density 
of pERK immunopositive neurons was observed in the STMV, co-expression of pERK and 
Rxfp3 mRNA was not significantly different between the groups (A2-pref, 20.25 ± 5.41%; 
vehicle, 10 ± 1.8%; n = 4; p = 0.25; Fig. 5g-h′′). 
 
Characterisation of Rxfp3 mRNA-expressing neurons in amygdala 
Multiplex fluorescence ISH was used to characterize key aspects of the neurochemical 
phenotype of Rxfp3 mRNA-expressing neurons. In the temporal extended amygdala, expression 
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of Rxfp3, Oxtr and Slc32a1 mRNA was examined (Table 2). In the MeAD, ~78% of the Rxfp3 
mRNA-expressing neurons were Slc32a1 mRNA-positive (GABAergic) (Fig. 7a-a′); 5% were 
Oxtr mRNA positive and ~12% were positive for Oxtr and Slc32a1 mRNA. Only ~5% of Rxfp3 
mRNA-expressing neurons were negative for the other mRNA species (Fig. 7b). 
In the MePV, 36% of Rxfp3 mRNA-expressing neurons were Slc32a1 mRNA-positive 
(GABAergic) (Fig. 7c-c′), ~20% were Oxtr mRNA-positive, and 11% expressed all three 
mRNA species. Furthermore, ~44% of Rxfp3 mRNA-expressing neurons expressed Oxtr 
mRNA (Fig. 7d). These data indicate that although a small proportion of Rxfp3 mRNA-
expressing neurons in the MeAD express Oxtr, this population is larger in the MePV, where 
~31-44% of the Rxfp3 mRNA-expressing neurons express Oxtr mRNA. Conversely, almost 
half the Oxtr mRNA-expressing neurons in the MeAD expressed Rxfp3 mRNA. Similarly, the 
percentage of Oxtr mRNA-expressing neurons that co-expressed Rxfp3 mRNA in the MePV 
ranged from 42-69%, probably due to variation in the total number of Rxfp3 mRNA-expressing 
neurons (Table 3). 
In the STMV, ~43% of neurons co-expressed Rxfp3 and Oxtr mRNA (Fig. 7g-h) and ~91% 
of these Rxfp3 mRNA-positive neurons were Slc32a1 mRNA-positive (Table 2 and 
Supplementary Fig. 2). In the OV, ~38% of Rxfp3 mRNA-expressing neurons expressed Oxtr 
mRNA. Furthermore, ~95% of Rxfp3 mRNA-positive neurons expressed Scl32a1 mRNA (i.e. 
GABAergic; Fig. 7e-f; Table 2; and Supplementary Fig. 2). These data indicate a significant 
proportion of Rxfp3 mRNA-positive neurons express Oxtr mRNA (38-43%), and ~89% of Oxtr 
mRNA-positive neurons in the OV and ~39% in the STMV express Rxfp3 mRNA (Table 3). 
 
DISCUSSION 
Social behaviour is characterized by a number of traits, including social recognition, motivation 
and reward, and is governed by complex brain processes (Dantzer et al. 1987; Gheusi et al. 
1994; Hurlemann et al. 2010; Trezza et al. 2011; Pellissier et al. 2017). In this study, we 
demonstrate that activation of relaxin-3 receptor (RXFP3) signalling broadly throughout the 
forebrain impaired SRM of a familiar conspecific in adult male rats. We employed the truncated 
RXFP3 agonist, RXFP3-A2, which is selective for RXFP3 (Shabanpoor et al. 2012; Zhang et 
al. 2015) and has previously been administered icv to demonstrate RXFP3 influences on various 
modalities, including food intake (de Ávila et al. 2018), anxiety-like behaviour (Ryan et al. 
2013a; Ma et al. 2017) and hippocampal-dependent spatial memory (Albert-Gascó et al. 2017). 
Global RXFP3 activation decreased discrimination between novel and familiar conspecific 
rats, but did not alter social discrimination between a rat and an object, as all experimental 
groups exhibited a similar preference to explore a conspecific rat rather than an inanimate 
object. Interestingly, RXFP3-A2 infusion prior to the sociability test also impaired SRM at both 
20 and 90 min post-infusion. A likely explanation for these findings is that RXPF3 signalling 
can inhibit memory formation when the agonist is present during the sociability test, and it can 
interfere with memory recall when present prior to and during the preference test. In both cases, 
RXFP3 agonist-treated rats were impaired during memory retrieval of familiar conspecifics, 
due to impaired memory formation and/or recall. 
Complex brain circuits are involved in SRM processes (Scalia and Winans 1975; Landgraf 
et al. 1995; Alheid et al. 1998; Ferguson et al. 2001), and it is thought that the ventral CA1 is 
the primary repository or store for social-related memories (Okuyama et al. 2016). Amygdala 
nuclei and regions of ST are centrally involved in memory formation, and in particular, the 
MeA has been strongly associated with SRM regulation (Ferguson et al. 2001; Lukas et al. 
2013; Gur et al. 2014), as it receives direct projections from centres involved in social 
processing (Scalia and Winans 1975). Notably, this social information is powerfully modulated 
by vasopressin (Everts and Koolhaas 1997; Veenema 2008; Gobrogge et al. 2009) and oxytocin 
(OT) systems. For example, OT gene knockout mice exhibit impaired SRM, and local infusions 
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of OT into the MeA rescued this social behaviour (Everts and Koolhaas 1997; Winslow et al. 
2000; Ferguson et al. 2001; Choleris et al. 2007; Veenema 2008). Furthermore, OT gene 
knockout mice exhibit decreased c-Fos expression in MeA, ST and medial preoptic area after a 
social interaction and memory test (Ferguson et al. 2001). 
In an effort to determine whether RXFP3 signalling affected neural activity in the 
amygdala, we examined ERK activation patterns following icv RXFP3-A2 administration. 
Western blot analysis revealed increased pERK immunoreactivity in amygdala extracts 20 min 
post-agonist infusion, compared to levels in vehicle-treated and naïve, untreated rats. At 90 min 
post-agonist infusion, pERK immunoreactivity levels were equivalent to basal levels in these 
control rats. Thus, the peak in ERK phosphorylation in the amygdala was reached during social 
recognition and preference encounters, and highlights the relevance of ERK activation in social 
learning and memory (Peng et al. 2010; Giese and Mizuno 2013); as well as the consistent 
influence of the RLN3/RXFP3 system on the amygdala (Ma et al. 2007; Pereira et al. 2013; 
Santos et al. 2016). 
Notably, in subsequent immunohistochemical studies, we detected an increase in pERK-
positive neurons in the MeA. In line with this finding, pERK was increased in the MeA of mice 
with social deficits compared to controls, after a sociability and preference test (Faridar et al. 
2014; Seese et al. 2014). Furthermore, in this model, oxytocin administration, improved social 
memory and reduced pERK levels in MeA, revealing a correlation between behavioural 
impairment and elevated pERK in MeA (Winslow et al. 2000; Winslow and Insel 2004). The 
observation that RXFP3 agonist treatment increased pERK levels in MeA and induced an 
impairment of SRM further supports the involvement of MeA signalling in social behaviour 
regulation. In anatomical studies, we confirmed the nature of the RLN3 innervation pattern 
within the amygdala (Santos et al. 2016) and noted several RLN3-positive nerve fibres making 
close contacts with pERK-immunopositive neurons in MeAD and MePV after the SRM task. 
In assessing the co-expression of RXFP3 mRNA and mRNA encoding other relevant 
neural markers, in the MeAD we observed that most Rxfp3 mRNA-positive neurons were 
GABAergic (90% Slc32a1 mRNA-positive), and 17% also expressed Oxtr mRNA. 
Furthermore, 46% of the Oxtr mRNA-expressing neurons in MeAD co-expressed Rxfp3 
mRNA. In contrast, in the MePV only 47% of Rxfp3 mRNA-positive neurons expressed 
Slc32a1 mRNA, while >60% of Oxtr mRNA-positive neurons co-expressed Rxfp3 mRNA. 
Activation of the oxytocin receptor (OTR), which is coupled to the excitatory Gq/11α class of G-
proteins that together with Gβγ stimulate the activity of phospholipase C-β isoform proteins 
(Shojo and Kaneko 2000), has been shown to produce neuronal excitation in the MeA (Terenzi 
and Ingram 2005), and presynaptic OTR activation promoted glutamate release (Mairesse et al. 
2015). In contrast, RXFP3 is coupled to inhibitory Gαi/o-proteins (Liu et al. 2003; Van der 
Westhuizen et al. 2007, 2010) and has been reported to hyperpolarize OT (and vasopressin) 
neurons in vitro (Kania et al. 2017). Thus, OTR and RXFP3 likely have directly opposing 
effects on the activity of some populations of amygdala neurons, and bidirectional regulatory 
mechanisms may exist between OT and RLN3 neurons, to regulate peptide release (Mairesse 
et al. 2015) and postsynaptic actions (Tyzio et al. 2006, 2014). 
In RXFP3-A2-treated rats, we also detected increased pERK levels in the STMV and OV 
nuclei, which are strongly interconnected with the cortical amygdala and the MeA (Gutiérrez-
Castellanos et al. 2014; Cádiz-Moretti et al. 2016) and have been implicated in social interaction 
and social memory (Ferguson et al. 2001; Bannerman et al. 2004; Takahashi et al. 2004; 
Kuhlmann et al. 2005). In these regions, Rxfp3 mRNA was predominantly expressed by 
GABAergic neurons (80% Slc32a1 mRNA-positive), and ~30% were Oxtr mRNA-positive. A 
major (39%) and minor (16%) proportion were Oxtr mRNA-positive in the MePV and the 
MeAD, respectively (Table 2). These findings suggest the RLN3/RXFP3 and OT/OTR systems 
may interact in the ST. In this regard, OT gene knockout mice displayed a specific decrease in 
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neuronal activation in ST after a social interaction and memory test (Ferguson et al. 2001). All 
areas studied in these experiments are also known to be in rodents important processing centres 
which precede elicitation of aggressive behaviours; these include MeA, ST, LS and 
hippocampus (Nelson and Trainor 2007). In addition, aggression is known to impair recognition 
of social cues and enhance impulsivity (Kruk 1991). Thus, there is a possibility that social 
recognition memory modulation by the RLN3/RXFP3 system could elicit aggressive cues. 
Specially interesting is if this effect is dimorphic given its impact over the ST (Everts et al. 
1997; Calvez et al. 2016). 
Taken together, the current findings have demonstrated that RXFP3 is expressed by 
GABAergic neurons in the extended amygdala, consistent with reports in other brain areas 
(Richter et al. 2005; Blasiak et al. 2013; Haidar et al. 2017; Albert-Gascó et al. 2017), which 
implies an overall disinhibitory effect of the RLN3/RXFP3 system within the amygdala. 
Furthermore, the presence and proportions of Rxfp3 and Oxtr mRNA-expressing neurons was 
broadly consistent across the different amygdaloid nuclei, suggesting a functional interaction 
between RXFP3 and OTR signalling, which warrants further investigation. Notably, OT has 
been implicated in the elicitation of social memory consolidation (Ferguson et al. 2001; Gur et 
al. 2014). As such, our results suggest a role for RLN3/RXFP3 signalling in modulating social 
memory, which might occur via rapid (direct and/or indirect) alterations in pERK and related 
signalling in GABAergic/peptidergic neurons within specific areas of the extended amygdala. 
Moreover, RXFP3 activation might be capable of modifying (antagonizing) the influence of 
OT/OTR signalling on MeA and ST neurons, in regulating (promoting) social behaviour, but 
further studies are now required to clarify the nature and complexity of this interaction. 
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Table 1. Relative density of pERK-immunopositive neurons in different areas of amygdala 









nucleus of the 
stria terminalis 
STMA 0.84 to -0.12 100 ± 18.5 136 ± 13.1 101 ± 7.9 0.078 
Ventromedial 
nucleus of the 
stria terminalis 
STMV 0.36 to -0.36 100 ± 21.9 275 ± 27.2* 
196 ± 
49.0 0.004 






















MePD -2.52 to -3.48 100 ± 13.0 146 ± 20.7 















Table 2. Proportion of Rxfp3 mRNA-expressing neurons in different areas of amygdala that co-






Triple Rxfp3 Total Rxfp3 






Triple Rxfp3 Total Rxfp3 
 18 32 10 29 89 
Rxfp3-Oxtr 1 Rxfp3-Oxtr Rxfp3 Total Rxfp3 
 44 55 98 
Rxfp3-Oxtr 2 Rxfp3-Oxtr Rxfp3 Total Rxfp3 
 27 37 64 
OV 
Rxfp3-Oxtr Rxfp3-Oxtr Rxfp3 Total Rxfp3 
 29 47 76 
Rxfp3-Slc32a1 Rxfp3-Slc32a1 Rxfp3 Total Rxfp3 
 118 6 124 
STMV 
Rxfp3-Oxtr Rxfp3/Oxtr Rxfp3 Total Rxfp3 
 10 13 30 
Rxfp3-Slc32a1 Rxfp3/Slc32a1 Rxfp3 Total Rxfp3 




Table 3. Proportion of Oxtr mRNA-expressing neurons that co-express Rxfp3 mRNA in 
different areas of amygdala 
MePV 
Probe Combination Rxfp3/Oxtr Total Oxtr 
Rxfp3-Oxtr-Slc32a1 22 66 
Rxfp3-Oxtr 1 52 77 
Rxfp3-Oxtr 2 33 48 
MeAD 
 Rxfp3/Oxtr Total Oxtr 
Rxfp3-Oxtr-Slc32a1 18 66 
OV 
Rxfp3-Oxtr 










Fig. 1 Social recognition memory is impaired after RXFP3 agonist infusion. (a) Timeline of 3-
chamber social interaction and memory and sociability tests, with infusion times indicated 
(black arrows). (b) Preference index for the sociability and (c) preference tests of experimental 
groups. First contact latency for the (d) sociability and (e) preference tests. ns, not significant; 
*p < 0.05; ***p < 0.001; ****p<0.0001. 
 
Fig. 2 pERK immunoreactivity is increased in amygdala after RXFP3 agonist infusion. (a, b) 
Rats sacrificed 20 min after icv infusion of RXFP3-A2 (~1 nmol; red bar) displayed 
significantly increased pERK in the amygdala area, compared to vehicle-treated (aCSF, white 
bar) and naïve rats (black bar). (c, d) Rats sacrificed 90 min after infusion exhibited similar 
pERK levels to those in the control groups. *p < 0.05; ***p < 0.001. 
 
Fig. 3 pERK immunostaining in the MeA after social encounters. (a) Schematic illustrating the 
MeAD and MePV nuclei analysed. (b) Density of pERK-stained neurons was significantly 
increased in A2-Pref rats (green bar) compared to vehicle (dashed black line). Representative 
images of pERK immunostaining in the MeAD of (c) vehicle, (d) A2-Pref and (e) A2-Soc 
groups. Representative images of pERK immunostaining in the MePV of (f) vehicle, (g) A2-
Pref and (h) A2-Soc groups. (i, j) RLN3-immunoreactive fibres (green) make close contact 
with pERK-positive neurons (red) in the (I) MeAD (i′, single plane orthogonal view) and (j) 
MePV (j′, single plane orthogonal view) of A2-Pref rats. *p < 0.05; **p < 0.01. Scale bars: 100 
µm (c), 10 µm (i, i′). 
 
Fig. 4 pERK immunostaining in the extended amygdala after social encounters. (a) Schematic 
illustrating the STMV, STMA and OV nuclei in the extended amygdala analyzed. (b) Density 
of pERK-stained cells was significantly increased in A2-Pref rats (green bars) compared to 
vehicle (dashed black line). Representative images of pERK immunostaining in the STMV of 
(c) vehicle, (d) A2-Pref and (e) A2-Soc rats. Representative images of pERK immunostaining 
in the OV of (f) vehicle, (g) A2-Pref and (h) A2-Soc rats. (i, j) RLN3-immunoreactive fibres 
(green) making close contact with pERK-positive neurons (red) in the (i) STMV (i′, single plane 
orthogonal view) and (j) OV (j′, single plane orthogonal view) of A2-Pref rats. *p < 0.05; **p 
< 0.01. Scale bars: 100 µm (c), 10 µm (i, i′). 
 
Fig. 5 pERK immunofluorescence and Rxfp3 mRNA co-expression in neurons of the extended 
amygdala. (a) Ratio of Rxfp3 mRNA-positive neurons, which display pERK immunoreactivity, 
(b) Ratio of pERK-immunopositive neurons that express Rxfp3 mRNA. *p < 0.05; ns: not 
significant. 
 
Fig. 6. pERK immunofluorescence and Rxfp3 mRNA co-expression in neurons of the extended 
amygdala. (a-b) Representative images illustrating pERK-immunopositive neurons, (a′-b′) 
Rxfp3 mRNA and merged signal (a′′, b′′) from vehicle and A2-pref group rats in the MeAD. 
(c, d) Representative images illustrating pERK-immunopositive neurons, (c′, d′) Rxfp3 mRNA 
and merged signal (c′′, d′) from vehicle and A2-pref group rats in the MePV. (e, f) 
Representative images illustrating pERK immunopositive neurons, (e′, f′) Rxfp3 mRNA and 
merged signal (e′′, f′′) from vehicle and A2-pref group rats in the OV. (g, h) Representative 
images illustrating pERK-immunopositive neurons, (g′-h′) Rxfp3 mRNA and merged signal 
(g′′, h′′) from vehicle and A2-pref group rats in the STMV. Scale bar: 25 µm (a). 
 
22 
Fig. 7 Characterization of the neurochemical phenotype of Rxfp3 mRNA-positive neurons in 
the extended amygdala. (a) Schematic illustrating Rxfp3 mRNA distribution and co-expression 
with Oxtr and Slc32a1 mRNA in the MeAD. (a′, b) Representative images of fluorescent ISH 
and quantification of co-expression percentages indicated (lower right corner). (c) Schematic 
illustrating Rxfp3 mRNA distribution and co-expression with Oxtr and Slc32a1 mRNA in the 
MePV (c′, d). (e) Schematic illustrating Rxfp3 mRNA distribution and co-expression with Oxtr 
mRNA in the STOV. (e′, f) Representative images of fluorescent ISH and co-expression 
percentages. (g) Schematic illustrating Rxfp3 mRNA distribution and co-expression with Oxtr 
mRNA in the STMV (g′, h). Scale bar: 100 µm (a′), 10 µm (b). 
 
Supplementary Figure Captions 
 
Supplementary Fig. 1. (a) Heat maps for the three-chamber social interaction paradigm for 
the sociability and preference tests. Percentages on the corners of the trackings refer to the 
average percentage time spent in each room. Percentages on the heat maps next to “subject”, 
“object” u “conspecifics” refer to the average percentage time spent sniffing. (b) Percentage 
time sniffing the conspecific rat (green bars) and inanimate object (black bars), or (c) the 
familiar (white bars) and novel rat (red bars) for the different experimental groups. * p<0.05, 
**** p<0.0001, ns: not significant. 
 
Supplementary Fig. 2. Characterisation of the neurochemical phenotype of Rxfp3 mRNA-
positive neurons in STMV an STOV. (a) Schematic illustrating Rxfp3 distribution and co-
expression with Oxtr mRNA in STMV (a′and b) Representative fluorescent images. 
Representative images of fluorescent ISH and quantification of co-expression percentages 
indicated (lower right corner). (c) Schematic illustrating Rxfp3 mRNA distribution and co-
expression with Oxtr and Slc32a1 mRNAs in the MePV. (c′ and d). Scale barS: 100 µm (a′), 
10µm (b) 
 
Supplementary Fig. 3. pERK immunostaining in the CeA after social encounters. (a) 
Schematic illustrating the CeA sub-nuclei analysed. (b) Density of pERK-stained neurons was 
significantly increased in A2-Pref rats (red bars) compared to vehicle treated rats (dashed 
black line). Representative images of pERK immunostaining in the CeA of (c) vehicle, (d) 
A2-Pref and (e) A2-Soc group rats. *p < 0.05; **p < 0.01. Scale bar: 100 µm (c). 
 
